ClassID:

20031

A61K9/0046 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Ear

Recent Application in this class:
#301
20170209524
2017-07-27

Methods and compounds to suppress viral genome release and packaging

#302
20170209498
2017-07-27

Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerve

#303
20170196804
2017-07-13

Method for the treatment of ear infections

#304
20170189477
2017-07-06

Methods and Compositions of P27KIP1 Transcriptional Modulators

#305
20170181967
2017-06-29

METHODS AND COMPOSITIONS FOR APPLYING PHARMACOLOGIC AGENTS TO THE EAR

#306
20170143675
2017-05-25

Formulations for treatment of hyperthyroidism

#307
20170128547
2017-05-11

Use of Hydrolytic and Oxidative Enzymes to Dissolve Biofilm in Ears

#308
20170128390
2017-05-11

DISINFECTANT AND ANTIMICROBIAL COMPOSITIONS, IN PARTICULAR FOR THE VETERINARY FIELD

#309
20170107264
2017-04-20

Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof

#310
20170105991
2017-04-20

Foamable otic pharmaceutical compositions

#311
20170105957
2017-04-20

Methods of treating ototoxicity

#312
20170100427
2017-04-13

Polysaccharide particle mixture

#313
20170100409
2017-04-13

Therapeutic agent for ocular fundus disease

#314
20170095481
2017-04-06

Compounds that enhance Atoh1 expression

#315
20170072007
2017-03-16

PHANTOM PHENOMENA TREATMENT

#316
20170071937
2017-03-16

Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss

#317
20170056455
2017-03-02

Method of identifying a biologically-active composition from a biofilm

#318
20170056454
2017-03-02

Method of identifying a biologically-active composition from a biofilm

#319
20170056447
2017-03-02

Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same

#320
20170056397
2017-03-02

Selective histamine H4 receptor antagonists for the treatment of vestibular disorders

#321
20170042916
2017-02-16

ANIMAL TISSUE COLONIZATION AND TREATMENT OF INFECTION

#322
20170042842
2017-02-16

Sensorineural hair cell differentiation

#323
20170029822
2017-02-02

Treatment using truncated Trk B and Trk C antagonists

#324
20170027930
2017-02-02

METHODS FOR THE TREATMENT OF PEDIATRIC OTIC DISORDERS

#325
20170027899
2017-02-02

Use of malononitrile compounds for protecting animals from parasites

#326
20170027865
2017-02-02

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#327
20170027859
2017-02-02

Methods and compounds to suppress viral genome release and packaging

#328
20170020809
2017-01-26

LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS

#329
20170000823
2017-01-05

Methods of treatment using topical copper ion formulations

#330
20170000728
2017-01-05

Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders

#331
20160362695
2016-12-15

Methods and compositions for neuroprotection

#332
20160361324
2016-12-15

METHOD OF TREATING MIDDLE EAR INFECTIONS

#333
20160339018
2016-11-24

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

#334
20160317546
2016-11-03

METHOD FOR TREATING OTIC INFECTIONS AFTER TYMPANOSTOMY TUBE PLACEMENT

#335
20160317467
2016-11-03

METHOD OF TREATING OR PREVENTING INFECTION

#336
20160310415
2016-10-27

CONTROLLED RELEASE COMPOSITIONS FOR MODULATING FREE-RADICAL INDUCED DAMAGE AND METHODS OF USE THEREOF

#337
20160289278
2016-10-06

GENES OF AN OTITIS MEDIA ISOLATE OF NONTYPEABLE HEAMOPHILUS INFLUENZAE

#338
20160279274
2016-09-29

Sterilization of ciprofloxacin composition

#339
20160279137
2016-09-29

FINAFLOXACIN SUSPENSION COMPOSITIONS

#340
20160271167
2016-09-22

METHOD FOR DETECTION TREATMENT AND PREVENTION OF NEUROLOGICAL DEVELOPMENT DISORDERS

#341
20160271148
2016-09-22

Chitosan-based matrices and uses thereof

#342
20160271147
2016-09-22

Chitosan-based matrices and uses thereof

#343
20160271098
2016-09-22

TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM

#344
20160271057
2016-09-22

Aqueous suspension preparation comprising nanoparticles of macrolide antibacterial agent

#345
20160256444
2016-09-08

Method and compositions for treatment or prevention of inflammatory conditions

#346
20160250231
2016-09-01

Solid drug implants for intracochlear delivery of therapeutics for the treatment of Otic disorders

#347
20160243285
2016-08-25

Methods of mammalian retinal stem cell production and applications

#348
20160243029
2016-08-25

Method of treating middle ear infections

#349
20160243028
2016-08-25

Auris formulations for treating otic diseases and conditions

#350
20160228435
2016-08-11

Arylamide compounds and compositions and uses thereof

#351
20160228357
2016-08-11

Auris Formulations for Treating Otic Diseases and Conditions

#352
20160220605
2016-08-04

Method for preventing nasolacrimal duct obstruction

#353
20160213592
2016-07-28

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#354
20160206711
2016-07-21

Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen

#355
20160199446
2016-07-14

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#356
20160199417
2016-07-14

Method of treatment utilizing an acellular amnion derived therapeutic composition

#357
20160095902
2016-04-07

Auris formulations for treating otic diseases and conditions

#358
20160090594
2016-03-31

Composition and method for inner ear sensory hair cell regeneration and replacement

#359
20160089333
2016-03-31

Foam-forming compositions and methods for delivering an active to a body cavity

#360
20160081931
2016-03-24

Powder composition for treating a disorder in the auditory canal of mammals and use thereof

#361
20160067383
2016-03-10

Agent for regenerating tympanic membrane or external auditory canal

#362
20160067179
2016-03-10

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#363
20160061818
2016-03-03

Islet1 (ISl1) and hearing loss

#364
20160051686
2016-02-25

Pharmaceutical compositions for treating ear diseases

#365
20160051681
2016-02-25

Transdermal pharmaceutical bases for treating ear disorders

#366
20160051547
2016-02-25

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#367
20160051516
2016-02-25

Method of treating disease by auricular anesthesia of cranial nerves

#368
20160045564
2016-02-18

Therapeutic use of a growth factor, METRNL

#369
20160038594
2016-02-11

CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#370
20160038491
2016-02-11

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#371
20160022666
2016-01-28

Systems and Methods for Treating Ear Disorders and Formulations Therefor

#372
20160022663
2016-01-28

Local cochlear application of statins for stimulating neurite regrowth in the cochlea

#373
20160008272
2016-01-14

Topical Copper Ion Treatments and Methods of Treatment Using Topical Copper Ion Treatments in the Oral-Respiratory-Otic Areas of the Body

#374
20160007610
2016-01-14

Antimicrobial wash

#375
20160002666
2016-01-07

Methods and compositions for treating genetically linked diseases of the eye

#376
20160000948
2016-01-07

Sterilization of ciprofloxacin composition

#377
20160000748
2016-01-07

Methods of treating topical microbial infections

#378
20160000742
2016-01-07

Methods of treating ototoxicity

#379
20150374779
2015-12-31

PHARMACOLOGIC TREATMENTS OF MENIÉRE'S DISEASE

#380
20150342965
2015-12-03

Foamable otic pharmaceutical compositions

#381
20150328229
2015-11-19

Compositions and methods for treating ophthalmic, octic, or nasal infections

#382
20150313839
2015-11-05

CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#383
20150313838
2015-11-05

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#384
20150313836
2015-11-05

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#385
20150306222
2015-10-29

Aqueous liquid bromfenac composition having preservative efficacy

#386
20150297588
2015-10-22

Sterile otic formulations

#387
20150290124
2015-10-15

Methods for the treatment of pediatric otic disorders

#388
20150283175
2015-10-08

System for treating ear infections

#389
20150265552
2015-09-24

Methods for the treatment of tinnitus induced by cochlear excitotoxicity

#390
20150250719
2015-09-10

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INNER EAR DISORDERS

#391
20150238419
2015-08-27

Partially absorbable fiber-reinforced composites for controlled drug delivery

#392
20150224163
2015-08-13

Treatment of noise induced hearing loss

#393
20150209367
2015-07-30

Treating Hearing Loss

#394
20150182454
2015-07-02

METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL

#395
20150164990
2015-06-18

Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss

#396
20150157607
2015-06-11

Compounds that enhance Atoh1 expression

#397
20150150915
2015-06-04

Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve

#398
20150150793
2015-06-04

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#399
20150133410
2015-05-14

TOPICAL OPHTHALMIC, OTIC, AND NASAL COMPOSITIONS OF CIPROFLOXACIN

#400
20150132238
2015-05-14

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#401
20150132237
2015-05-14

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#402
20150119371
2015-04-30

TOPICAL PHARMACEUTICAL COMPOSITIONS OF ANTIBIOTICS AND STEROIDAL ANTI INFLAMMATORY AGENTS

#403
20150104494
2015-04-16

METHODS FOR REPAIR OF EAR CANAL TISSUE DEFECTS

#404
20150068539
2015-03-12

Systems and methods for anesthetizing ear tissue

#405
20150057360
2015-02-26

Methods for the treatment of tinnitus induced by cochlear excitotoxicity

#406
20150044271
2015-02-12

SOLID DRUG IMPLANTS FOR INTRACOCHLEAR DELIVERY OF THERAPEUTICS FOR THE TREATMENT OF OTIC DISORDERS

#407
20150038441
2015-02-05

Kit-in-parts for cleaning and treating ears of companion animals

#408
20150037391
2015-02-05

Local administration of gallium compositions to treat pain

#409
20150030568
2015-01-29

Use of stem cells to generate inner ear cells

#410
20150025096
2015-01-22

Small molecule compounds to treat hearing loss

#411
20150017103
2015-01-15

Compositions with modulating agents

#412
20150011653
2015-01-08

Novel Microbial Pathogen inhibitor

#413
20140378395
2014-12-25

Peptides for the Treatment of Hearing

#414
20140364836
2014-12-11

Pharmaceutical compositions for the treatment of inner ear disorders

#415
20140364403
2014-12-11

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#416
20140364383
2014-12-11

Methods and compositions for applying pharmacologic agents to the ear

#417
20140363511
2014-12-11

Method of treating middle ear infections

#418
20140348898
2014-11-27

Local administration of gallium compositions to treat pain

#419
20140323433
2014-10-30

Method for rehydrating polysaccharide particles

#420
20140315788
2014-10-23

Methods for improving muscle and heart function

#421
20140309217
2014-10-16

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#422
20140286884
2014-09-25

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#423
20140271495
2014-09-18

Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body

#424
20140271494
2014-09-18

Wax foamable vehicle and pharmaceutical compositions thereof

#425
20140243425
2014-08-28

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#426
20140228782
2014-08-14

Methods and devices for delivery of pharmaceutical agents within orifices of the body

#427
20140228444
2014-08-14

Otic composition for companion animals

#428
20140205683
2014-07-24

Method for preventing nasolacrimal duct obstruction

#429
20140180195
2014-06-26

Drug-delivery accessory for an implantable medical device

#430
20140162990
2014-06-12

Finafloxacin suspension compositions

#431
20140107423
2014-04-17

System and methods for treating ear disorders

#432
20140087006
2014-03-27

Use of transplatin to prevent hearing loss

#433
20140080793
2014-03-20

Pharmaceutical compositions with phosphonium antimicrobial agents

#434
20140066493
2014-03-06

Compositions and methods for treatment of ear disorders

#435
20140051670
2014-02-20

Compositions containing moxifloxacin for treating otic infections

#436
20140044667
2014-02-13

Healing composition for topical application

#437
20140018395
2014-01-16

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#438
20130331385
2013-12-12

Methods for treating otic infections

#439
20130323327
2013-12-05

Method for preventing nasolacrimal duct obstruction

#440
20130323297
2013-12-05

Local administration of gallium compositions to treat pain

#441
20130315996
2013-11-28

Bio-functionalized stimulus-responsive dissolvable PEG-hydrogels

#442
20130303615
2013-11-14

Antimicrobial compositions and methods

#443
20130281537
2013-10-24

Aqueous liquid bromfenac composition having preservative efficacy

#444
20130280340
2013-10-24

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#445
20130266652
2013-10-10

Liquid pharmaceutical composition for the delivery of active ingredients

#446
20130216609
2013-08-22

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#447
20130210889
2013-08-15

Composition and method for inner ear sensory hair cell regeneration and replacement

#448
20130189241
2013-07-25

Regulated delivery systems for inner ear drug application and uses thereof

#449
20130178801
2013-07-11

Otic formulations, methods and devices

#450
20130178434
2013-07-11

Method of treating otitis externa using macrocyclic lactone compound

#451
20130150410
2013-06-13

Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders

#452
20130116210
2013-05-09

Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

#453
20130085476
2013-04-04

System and method for delivery of a therapeutic agent to the inner ear

#454
20130065818
2013-03-14

Arylamide compounds and compositions and uses thereof

#455
20130064911
2013-03-14

Method and formulation for treating dry ear inflammation with cortisone

#456
20130045957
2013-02-21

Prevention of and Recovery from Drug-Induced Ototoxicity

#457
20130041331
2013-02-14

Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead

#458
20130034595
2013-02-07

Local administration of gallium compositions to treat pain

#459
20130028958
2013-01-31

Beta-carbolines for use in the treatment of hearing loss and vertigo

#460
20130023575
2013-01-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE ALLERGIES

#461
20120328580
2012-12-27

Compounds that enhance Atoh1 expression

#462
20120302554
2012-11-29

PHANTOM PHENOMENA TREATMENT

#463
20120289541
2012-11-15

METHODS AND COMPOSITIONS FOR APPLYING MOXIFLOXACIN TO THE EAR

#464
20120277199
2012-11-01

Modulation of Gel Temperature of Poloxamer-Containing Formulations

#465
20120258921
2012-10-11

Peptides for the treatment of hearing

#466
20120252875
2012-10-04

Methods and compositions for treating diseases, disorders or injury of the CNS

#467
20120252720
2012-10-04

Compositions for treatment of ear disorders and methods of use thereof

#468
20120222141
2012-08-30

Islet1 (Isl1) and hearing loss

#469
20120214833
2012-08-23

SOLID DISPERSION OF RIFAXIMIN

#470
20120213717
2012-08-23

Soothing Agents

#471
20120208848
2012-08-16

GACYCLIDINE FORMULATIONS

#472
20120190671
2012-07-26

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#473
20120171275
2012-07-05

Local administration of gallium compositions to treat pain

#474
20120158114
2012-06-21

COCHLEAR IMPLANT DRUG DELIVERY DEVICE

#475
20120135087
2012-05-31

Topical compositions designed to maintain or restore the integrity of the mucous membranes

#476
20120101426
2012-04-26

Method for transdermal delivery of permeant substances

#477
20120100191
2012-04-26

Methods and devices for delivery of pharmaceutical agents within orifices of the body

#478
20120082627
2012-04-05

OTIC FOAM FORMULATIONS

#479
20120071395
2012-03-22

Treatment of allergic otitis media in mammals with neurotoxins

#480
20120053161
2012-03-01

TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN

#481
20120046259
2012-02-23

Composition comprising an antibiotic and a corticosteroid

#482
20120039913
2012-02-16

Selective histamine H4 receptor antagonists for the treatment of vestibular disorders

#483
20120003174
2012-01-05

OTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS OF THE INTERNAL AND EXTERNAL EAR IN MAMMALS

#484
20110319377
2011-12-29

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#485
20110319375
2011-12-29

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#486
20110319374
2011-12-29

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#487
20110319373
2011-12-29

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#488
20110311462
2011-12-22

Compositions for treatment of ear disorders and methods of use thereof

#489
20110288468
2011-11-24

Drug-delivery accessory for an implantable medical device

#490
20110281833
2011-11-17

Composition for the treatment of ear infections and method

#491
20110281809
2011-11-17

Methods and compositions for rapid treatment of otitis externa

#492
20110280964
2011-11-17

Composition and method of treating hearing loss

#493
20110274676
2011-11-10

Topical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections

#494
20110269719
2011-11-03

PHARMACEUTICAL COMPOSITIONS WITH PHOSPHONIUM ANTIMICROBIAL AGENTS

#495
20110263652
2011-10-27

Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor

#496
20110263587
2011-10-27

REVERSIBLY HEAT-GELABLE AQUEOUS COMPOSITION

#497
20110223126
2011-09-15

OPHTHALMIC COMPOSITION

#498
20110212932
2011-09-01

Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation

#499
20110208161
2011-08-25

INTRACOCHLEAR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM

#500
20110182874
2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#501
20110182873
2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#502
20110177050
2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

#503
20110177049
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#504
20110177048
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

#505
20110171189
2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#506
20110166060
2011-07-07

Tympanic membrane permeating ear drops and uses thereof

#507
20110150975
2011-06-23

Treatment of sinusitis in mammals with clostridia neurotoxins

#508
20110142917
2011-06-16

Compositions and methods for treatment of ear disorders

#509
20110142819
2011-06-16

METHOD OF IMPROVING WOULD HEALING

#510
20110136870
2011-06-09

GACYCLIDINE FORMULATIONS

#511
20110135646
2011-06-09

Genes of an otitis media isolate of nontypeable

#512
20110129454
2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#513
20110112035
2011-05-12

Therapeutic use of a growth factor, METRNL

#514
20110111052
2011-05-12

Apparatus and method to generate a mixture of hydrogen peroxide gas and a carrier gas

#515
20110110987
2011-05-12

Agent for regenerating tympanic membrane or external auditory canal

#516
20110098266
2011-04-28

Method of administering an injectable antibiotic to an animal

#517
20110097408
2011-04-28

CHITOSAN-BASED MATRICES AND USES THEREOF

#518
20110091505
2011-04-21

Treatment of asthma in mammals with clostridia neurotoxins

#519
20110091504
2011-04-21

Treatment of allergic rhinitis in mammals with neurotoxins

#520
20110086072
2011-04-14

Treatment of infectious rhinitis in mammals with clostridia neurotoxins

#521
20110082125
2011-04-07

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

#522
20110040226
2011-02-17

Cold ionizing radiation sterilization

#523
20110034430
2011-02-10

Phospholipid gel compositions for drug delivery and methods of treating conditions using same

#524
20110014302
2011-01-20

Use of transplatin to prevent hearing loss

#525
20110008456
2011-01-13

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#526
20110003803
2011-01-06

Methods for treating ophthalmic, otic, or nasal infections

#527
20100324151
2010-12-23

METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFECTION OR INFECTIOUS COLONIZATION OF THE EYELID, OCULAR SURFACE, SKIN OR EAR

#528
20100305054
2010-12-02

CONCENTRATED AQUEOUS AZALIDE FORMULATIONS

#529
20100297271
2010-11-25

Compositions and methods for reducing hepatotoxicity associated with drug administration

#530
20100273864
2010-10-28

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#531
20100247694
2010-09-30

COMPOSITION AND METHOD FOR TREAMENT OF INFLAMATION AND INFECTIONS OF THE OUTER EAR CANAL, NOSE AND PARANASAL SINUSES

#532
20100239518
2010-09-23

OPHTHALMIC COMPOSITION

#533
20100227879
2010-09-09

Liquid formulations for treatment of diseases or conditions

#534
20100222308
2010-09-02

OPHTHALMIC, OTIC OR NASAL PHARMACEUTICAL COMPOSITION AND THE USE THEREOF

#535
20100221340
2010-09-02

METHOD AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF INFLAMMATORY CONDITIONS

#536
20100209411
2010-08-19

USE OF HYDROLYTIC AND OXIDATIVE ENZYMES TO DISSOLVE BIOFILM IN EARS

#537
20100198135
2010-08-05

Systems and methods for anesthetizing ear tissue

#538
20100197811
2010-08-05

AQUEOUS COMPOSITION

#539
20100178255
2010-07-15

Composition and method to treat otitis media and ventilator- associated pneumonia

#540
20100144719
2010-06-10

Pharmaceutical suspension

#541
20100135935
2010-06-03

Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications

#542
20100121422
2010-05-13

Hydrogel-filled drug delivery reservoirs

#543
20100121256
2010-05-13

Implantable and Refillable Drug Delivery Reservoir

#544
20100120712
2010-05-13

Pharmaceutical composition for meniere's disease

#545
20100087409
2010-04-08

COMPOSITION COMPRISING AN ANTIBIOTIC AND A CORTICOSTEROID

#546
20100056537
2010-03-04

PHARMACEUTICAL COMPOSITION HAVING RELATIVELY LOW IONIC STRENGTH

#547
20100048522
2010-02-25

Method of treating otic infections with moxifloxacin compositions

#548
20100036000
2010-02-11

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#549
20100028398
2010-02-04

CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS

#550
20100022661
2010-01-28

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#551
20100021416
2010-01-28

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#552
20100016450
2010-01-21

CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS

#553
20100016218
2010-01-21

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#554
20100015263
2010-01-21

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#555
20100015228
2010-01-21

Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

#556
20100009952
2010-01-14

Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

#557
20090325938
2009-12-31

CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#558
20090324552
2009-12-31

Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

#559
20090306225
2009-12-10

Auris formulations for treating otic diseases and conditions

#560
20090298956
2009-12-03

SELF-PRESERVED EMULSIONS

#561
20090297533
2009-12-03

Controlled release immunomodulator compositions and methods for the treatment of otic disorders

#562
20090292237
2009-11-26

Modular drug delivery system for minimizing trauma during and after insertion of a cochlear lead

#563
20090291911
2009-11-26

Rehydratable polysaccharide particles and sponge

#564
20090269417
2009-10-29

THIOLATED CHITOSAN GEL

#565
20090263345
2009-10-22

Otic compositions for the treatment of infections of the internal and external ear in mammals

#566
20090253807
2009-10-08

Aqueous suspension preparations

#567
20090246255
2009-10-01

Pharmaceutical Compositions for the Treatment of Inner Ear Disorders

#568
20090239831
2009-09-24

Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis

#569
20090238907
2009-09-24

Methods of inhibiting growth of bacteria, yeast, fungus, and virus with and extracellular products

#570
20090232780
2009-09-17

Compounds that enhance Atoh1 expression

#571
20090215735
2009-08-27

TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN

#572
20090202663
2009-08-13

Pharmaceutical composition for the treatment of otomycosis

#573
20090186057
2009-07-23

Topical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections

#574
20090156566
2009-06-18

Method of treating middle ear infections

#575
20090155390
2009-06-18

Composition and method of treating temporary and permanent hearing loss

#576
20090137539
2009-05-28

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

#577
20090124568
2009-05-14

Screening method for compounds that promote differentiation of inner ear progenitor cells

#578
20090111773
2009-04-30

Compositions and methods of using lamellar bodies for modifying linear biological macromolecules

#579
20090093449
2009-04-09

Concentrated aqueous azalide formulations

#580
20090092574
2009-04-09

Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof

#581
20090069435
2009-03-12

Bridged polycyclic compound based compositions for topical applications for pets

#582
20090062896
2009-03-05

Minimizing trauma during and after insertion of a cochlear lead

#583
20090041680
2009-02-12

Wax foamable vehicle and pharmaceutical compositions thereof

#584
20090017098
2009-01-15

Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube

#585
20090011045
2009-01-08

Pharmaceutical for Hygienic Administration in the Ear

#586
20080318918
2008-12-25

Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear

#587
20080306039
2008-12-11

Loteprednol Etabonate Aqueous Suspension

#588
20080287672
2008-11-20

Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

#589
20080269187
2008-10-30

Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear

#590
20080267929
2008-10-30

Use of stem cells to generate inner ear cells

#591
20080255096
2008-10-16

Phantom Phenomena Treatment

#592
20080248135
2008-10-09

Combination Therapy for Otitis with Antiseptic and pH Adjustment

#593
20080214513
2008-09-04

METHOD OF TREATING MIDDLE EAR INFECTIONS

#594
20080206159
2008-08-28

Compositions with modulating agents

#595
20080199400
2008-08-21

Otologic nanotechnology

#596
20080181951
2008-07-31

Treatment of humans with colloidal silver composition

#597
20080166436
2008-07-10

Composition for normalizing otitis externa in mammals

#598
20080124385
2008-05-29

Methods for Transmembrane Treatment and Prevention of Otitis Media

#599
20080124271
2008-05-29

Method for preventing nasolacrimal duct obstruction

#600
20080113004
2008-05-15

Local administration of gallium compositions to treat pain